300313 ST天山生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资13,23913.99%11,61410,8569,5858,751
投资性房地产33,325-4.81%35,00946,41948,56644,599
固定资产68,213-3.01%70,33366,69972,113213,814
在建工程0--0007
无形资产63,911-2.75%65,71569,15472,682105,233
商誉0--0000
其他非流动资产22,6915.55%21,49821,81923,654459,931
201,379-1.37%204,169214,949226,601832,334

流动资产
货币资金18,65011.44%16,73547,288108,88316,302
应收账款11,070-6.83%11,8827,96727,1189,672
存货60,142-17.01%72,46554,17128,85745,788
其他流动资产5,296-46.93%9,9798,2127,7362,924
95,158-14.32%111,060117,638172,59474,685

流动负债
短期借款83,027-0.02%83,04294,160141,692218,290
应付票据0--0000
应付帐款17,903-7.51%19,35610,89812,36413,560
其他流动负债131,3343.19%127,273120,702118,811513,784
232,2641.13%229,671225,759272,867745,633
流动资产净值(137,107)15.59%(118,610)(108,121)(100,272)(670,948)
资产总额减流动负债64,273-24.88%85,559106,827126,329161,386

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债18,60337.13%13,56612,75111,96912,320
18,60337.13%13,56612,75111,96912,320

总权益
    实收股本312,9770.00%312,977312,977312,977312,977
    储备项目(278,648)11.10%(250,809)(228,807)(208,848)(158,009)
股东权益34,330-44.78%62,16984,170104,129154,969
非控股权益11,33915.42%9,8249,90610,230(5,903)